Medtronic (MDT) Tops Q2 EPS by 3c; Nudges FY16 EPS Midpoint Higher

Medtronic (NYSE: MDT) reported Q2 EPS of $1.03, $0.03 better than the analyst estimate of $1.00. Revenue for the quarter came in at $7.1 million versus the consensus estimate of $7.06 million.

GUIDANCE:

Medtronic sees FY16 EPS of $4.33-$4.40, versus prior guidance of $4.30-$4.40 and the consensus of $4.36.

For earnings history and earnings-related data on Medtronic (MDT) click here.

You May Also Be Interested In

• Procter & Gamble (PG) revenue falls short of expectations, raises full-year earnings guidance
• BancFirst Corp. (BANF) Tops Q1 EPS by 11c
• Fifth Third Bancorp (FITB) Tops Q1 EPS by 2c